Recent

% | $
Quotes you view appear here for quick access.

Thoratec Corporation Message Board

  • professor4everyone professor4everyone May 6, 2003 8:37 AM Flag

    The Amazing LVAD

    This LVAD technology can [not] be stopped or even slowed. Not only are Hearts being cured (Bridge To Recovery), but [other bodily organs] are recovering under the LVAD. Moreover we see Heart Muscle scars healed with the combination of MyoBlast Technology working with LVADs. Then we have the Yacoub Technology (LVADs working with Drugs) to allow dying emaciated patients to heal and play football months later. For those who have not seen some of the LVAD excitement, review those below from major Hospitals.
    ************************
    "What is clear is that we are only able to do heart transplants on 2,500 patients each year," said Dr. Sidney Smith, chief science officer for the American Heart Association. And as there are 40,000 people in end-stage heart failure, "there is a great need for new strategies," he said.

    -Columbia University-�VADs have gained widespread acceptance as bridge to transplant and bridge to recovery therapy.�

    -Baylor College Of Medicine-"Therefore, we propose that the combined therapies, therapeutic VAD and therapeutic apheresis, will provide a prominent outcome for a patient who is suffering from end-stage heart failure."

    California Pacific Medical Center, San Francisco,-�Long-term survival for bridge-to-recovery with VADs for acute cardiomyopathies and myocarditis is equivalent to that for cardiac transplantation. Recovery of the native heart, which can take weeks to months of VAD support, is the most desirable clinical outcome and should be actively sought, with transplantation used only after recovery of ventricular function has been ruled out.�

    -University of Minnesota: nearly half of the 5 million Americans with damaged hearts didn't get that way from heart attacks. Their heart failures are caused by high blood pressure, toxic reactions, alcoholism and other conditions,. Dr. Miller said he sees about six or seven patients a year with sudden heart failure unrelated to a heart attack. Now, he said, "I would put a pump in every one of them" with the hope that their hearts might recover.
    The Minneapolis doctors plan to join forces with other researchers who have used the heart pump and drugs to achieve surprising results

    -It took an average of six months on the pump for the hearts to recover, and the patients -- once near death -- since have returned to work, Sir Magdi Yacoub said at the annual meeting of the European Society of Cardiology.

    Their hearts have been functioning normally for an average of a year, with one patient reaching four years, Yacoub said.

    "I've been around for 35 years and this is the most exciting thing I've seen in my whole career," said Yacoub, a pioneering heart transplant surgeon. "You have someone who's so sick he is emaciated, then you have him running in the park, playing football, or whatever."

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • "The U of Maryland article that LVADs [improve] organ function is a pure endorsement of yet another reason to own a piece of the remarkable LVAD technology. See below:

      " The researchers also found that there was clear [improvement] in both kidney and liver function with heart pump support over several weeks. "As patients start to rehabilitate," says Dr. Gammie, "they [get up], they start to [walk around], they're [exercising], and [their kidneys and liver begin to work well]."

      • 2 Replies to professor4everyone
      • "The U of Maryland article that LVADs [improve] organ function is a pure endorsement of yet another reason to own a piece of the remarkable LVAD technology. See below:

        " The researchers also found that there was clear [improvement] in both kidney and liver function with heart pump support over several weeks. "As patients start to rehabilitate," says Dr. Gammie, "they [get up], they start to [walk around], they're [exercising], and [their kidneys and liver begin to work well]."

      • 18th Annual Scientific Meeting of the Australasian Society of Cardiovascular Perfusionists at the November 9-10, 2001 Windsor Hotel, Melbourne, Australia

        ABSTRACTS

        Bridge To Recovery Of The "Damaged" Heart
        M.Mennen, H.Fukuda, K.N. Waters, J.A. Mack, D.S. Esmore

        Heart and Lung Transplant Service, The Alfred, Melbourne, Victoria, Australia.��������������������������������������.
        Of the 12 bridge to recovery 9 (67%) have therefore been successfully weaned from a Thoratec-based combination of devices. The actuarial survival curve is depicted in Figure 1.

        The Thoratec VAD with its unique deployment flexibility remains a pivotal device in facilitating "recovery" of the reversibly damaged heart

 
THOR
63.500.00(0.00%)Oct 8 4:00 PMEDT